JNJJohnson & Johnson
232.15EUR-1.15%Mkt Cap: 611.12B $P/E: 31.36

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine…

Key Statistics

Company
Market Cap611.12B $
Enterprise Value641.72B $
Revenue (TTM)106.44B $
Gross Profit69.50B $
Net Income (TTM)29.13B $
Revenue/Share44.20 USD
Last Price232.15 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees138.2K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS4781601046
Valuation
P/E (Trailing)31.36
P/E (Forward)
PEG4.55
EV/EBITDA16.93
EV/Revenue6.03
P/S5.74
P/B7.63
EPS (TTM)7.44
EPS (Forward)
52W Range
227.5554% of range236.10
52W High236.10 EUR
52W Low227.55 EUR
Profitability
Gross Margin67.88%
Oper. Margin29.19%
EBITDA Margin35.61%
Profit Margin28.46%
ROE32.87%
ROA13.46%
Growth
Revenue Growth6.60%
Earnings Growth-0.90%
Cash Flow & Leverage
Operating CF26.66B $
CapEx (TTM)5.67B $
FCF Margin17.24%
FCF Yield3.00%
Net Debt30.74B $
Net Debt/EBITDA0.81
Balance Sheet
Debt/Equity0.59
Current Ratio1.09
Quick Ratio0.72
Book Value/Sh30.57 EUR
Cash/Share8.614 EUR
Dividends
Fwd Div Rate4.710 EUR
Trail. Div Rate5.240 EUR
Div. Yield2.07%
5Y Avg Yield2.77%
Payout Ratio60.79%
Ex-Div DateAug 25, 2026
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.2.41B
Float2.41B
Insiders0.05%
Institutions77.23%
Technical
SMA 50220.25 (+5.4%)
SMA 200199.57 (+16.3%)
Beta0.23
S&P 52W Chg20.80%
Avg Vol (30d)5.15K
Avg Vol (10d)1.89K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)